导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.41% | 428/1050 |
| 近一周 | -3.68% | 921/1104 |
| 近一月 | -3.76% | 454/1102 |
| 近一季 | -7.76% | 568/1092 |
| 近半年 | -1.92% | 473/1070 |
| 近一年 | 16.68% | 273/1018 |
| 近两年 | 76.98% | 312/926 |
| 近三年 | 57.29% | 211/834 |
| 成立以来 | 245.99% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.66% 607/1070 |
15.48% 440/1101 |
- - |
- - |
| 2025 | 55.07% 148/1065 |
2.53% 603/1014 |
1.29% 568/1038 |
42.17% 157/1050 |
5.02% 138/1065 |
| 2024 | 3.37% 486/1011 |
3.28% 155/960 |
2.13% 192/983 |
9.47% 664/991 |
-10.48% 917/1011 |
| 2023 | -14.10% 485/952 |
1.28% 553/880 |
-4.21% 469/895 |
-7.50% 466/915 |
-4.28% 430/952 |
| 2022 | -26.23% 535/867 |
-21.21% 589/773 |
8.89% 302/806 |
-11.96% 386/845 |
-2.34% 553/867 |
| 2021 | 9.38% 257/740 |
-1.75% 213/580 |
13.09% 286/659 |
-2.91% 289/704 |
1.39% 379/740 |
| 2020 | 55.14% 216/554 |
-5.41% 301/419 |
24.30% 204/466 |
4.16% 373/517 |
26.68% 54/554 |
| 2019 | 64.57% 60/410 |
31.97% 263/1146 |
-4.00% 647/1228 |
14.04% 49/390 |
13.90% 73/410 |
| 2018 | -12.44% 16/349 |
- - |
-8.65% 402/990 |
-2.31% 326/1000 |
-7.69% 135/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中欧时代先锋股票C VS. 东吴新产业精选股票A(580008) |